Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis

NCT07335887 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

AL Amyloidosis (AL)
t(11;14) Positive

Interventions

DRUG: sonrotoclax
DRUG: Daratumumab
DRUG: Dexamethasone

Sponsor

Peking University People's Hospital